Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life

Table 2

Comparison of the data between baseline and the follow-up by using ANOVA test and the Bonferroni post hoc test.

	Baseline	1 month	3 months	Baseline vs. 1 month	1 month vs. 3 months	Baseline vs. 3 months
	Mean (SD)	Mean (SD)	Mean (SD)	value	value	value
Eyelid erythema	0.46 (0.82)	0.23 (0.55)	0.13 (0.37)	<0.001	<0.001	<0.001
Conjunctival hyperaemia	0.97 (0.94)	0.58 (0.64)	0.33 (0.52)	<0.001	<0.001	<0.001
Follicular hyperplasia	0.36 (0.62)	0.16 (0.40)	0.08 (0.31)	<0.001	<0.001	<0.001
Beak-up time (sec)	9.82 (0.31)	10.9 (3.24)	11.5 (3.38)	<0.001	<0.001	<0.001
Schirmer test (min)	13.46 (6.28)	14.72 (6.44)	15.41 (6.32)	<0.001	<0.001	<0.001

From [95].